Efficacy of low-dose oral metronomic dosing of the prodrug of gemcitabine, LY2334737, in human tumor xenografts.
Saved in:
| Title: | Efficacy of low-dose oral metronomic dosing of the prodrug of gemcitabine, LY2334737, in human tumor xenografts. |
|---|---|
| Authors: | Pratt SE; Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN 46285, USA. Pratt_Susan_E@lilly.com, Durland-Busbice S, Shepard RL, Donoho GP, Starling JJ, Wickremsinhe ER, Perkins EJ, Dantzig AH |
| Source: | Molecular cancer therapeutics [Mol Cancer Ther] 2013 Apr; Vol. 12 (4), pp. 481-90. Date of Electronic Publication: 2013 Jan 31. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: American Association for Cancer Research, Inc Country of Publication: United States NLM ID: 101132535 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1538-8514 (Electronic) Linking ISSN: 15357163 NLM ISO Abbreviation: Mol Cancer Ther Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 23371859 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Efficacy of low-dose oral metronomic dosing of the prodrug of gemcitabine, LY2334737, in human tumor xenografts. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Pratt+SE%22">Pratt SE</searchLink>; Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN 46285, USA. Pratt&#95;Susan&#95;E@lilly.com<br /><searchLink fieldCode="AU" term="%22Durland-Busbice+S%22">Durland-Busbice S</searchLink><br /><searchLink fieldCode="AU" term="%22Shepard+RL%22">Shepard RL</searchLink><br /><searchLink fieldCode="AU" term="%22Donoho+GP%22">Donoho GP</searchLink><br /><searchLink fieldCode="AU" term="%22Starling+JJ%22">Starling JJ</searchLink><br /><searchLink fieldCode="AU" term="%22Wickremsinhe+ER%22">Wickremsinhe ER</searchLink><br /><searchLink fieldCode="AU" term="%22Perkins+EJ%22">Perkins EJ</searchLink><br /><searchLink fieldCode="AU" term="%22Dantzig+AH%22">Dantzig AH</searchLink> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101132535%22">Molecular cancer therapeutics</searchLink> [Mol Cancer Ther] 2013 Apr; Vol. 12 (4), pp. 481-90. <i>Date of Electronic Publication: </i>2013 Jan 31. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Association+for+Cancer+Research%2C+Inc%22">American Association for Cancer Research, Inc </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101132535 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1538-8514 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2215357163%22">15357163 </searchLink><i>NLM ISO Abbreviation: </i>Mol Cancer Ther <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=23371859 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1158/1535-7163.MCT-12-0654 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 481 Titles: – TitleFull: Efficacy of low-dose oral metronomic dosing of the prodrug of gemcitabine, LY2334737, in human tumor xenografts. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Pratt SE – PersonEntity: Name: NameFull: Durland-Busbice S – PersonEntity: Name: NameFull: Shepard RL – PersonEntity: Name: NameFull: Donoho GP – PersonEntity: Name: NameFull: Starling JJ – PersonEntity: Name: NameFull: Wickremsinhe ER – PersonEntity: Name: NameFull: Perkins EJ – PersonEntity: Name: NameFull: Dantzig AH IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 04 Text: 2013 Apr Type: published Y: 2013 Identifiers: – Type: issn-electronic Value: 1538-8514 Numbering: – Type: volume Value: 12 – Type: issue Value: 4 Titles: – TitleFull: Molecular cancer therapeutics Type: main |
| ResultId | 1 |